| Literature DB >> 29847104 |
Georgios Pantouris1, Richard Bucala2,3, Elias J Lolis1,3.
Abstract
We report the first reversible and selective small molecule inhibitor of pro-inflammatory protein macrophage migration inhibitory factor-2 (also known as MIF-2 or d-DT). 4-(3-Carboxyphenyl)-2,5-pyridinedicarboxylic acid (4-CPPC) shows competitive binding with a 13-fold selectivity for human MIF-2 versus human MIF-1. The crystal structure of MIF-2 complexed with 4-CPPC reveals an induced fit mechanism that is not observed in the numerous MIF-1/inhibitor complexes. Crystallographic analysis demonstrates the structural source of 4-CPPC binding and selectivity for MIF-2. 4-CPPC can be employed to reveal previously unrecognized functions of MIF-1 in biological systems in which both MIF-1 and MIF-2 are expressed, to improve our knowledge of the MIF family of proteins, and to provide new mechanistic insights that can be utilized for the development of potent and selective pharmacological modulators of MIF-2.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29847104 PMCID: PMC6123015 DOI: 10.1021/acs.biochem.8b00344
Source DB: PubMed Journal: Biochemistry ISSN: 0006-2960 Impact factor: 3.162